A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Metyrosine
Lurasidone
The risk or severity of hypertension can be increased when Dutasteride is combined with Lurasidone.
Metyrosine
Parecoxib
The risk or severity of hypertension can be increased when Dutasteride is combined with Parecoxib.
Metyrosine
Vilazodone
The risk or severity of hypertension can be increased when Dutasteride is combined with Vilazodone.
Metyrosine
Asenapine
The risk or severity of hypertension can be increased when Dutasteride is combined with Asenapine.
Metyrosine
Nylidrin
The risk or severity of hypertension can be increased when Dutasteride is combined with Nylidrin.
Metyrosine
Mianserin
The risk or severity of hypertension can be increased when Dutasteride is combined with Mianserin.
Metyrosine
Cariprazine
The risk or severity of hypertension can be increased when Dutasteride is combined with Cariprazine.
Metyrosine
Rotigotine
The risk or severity of hypertension can be increased when Dutasteride is combined with Rotigotine.
Metyrosine
Indacaterol
The risk or severity of hypertension can be increased when Dutasteride is combined with Indacaterol.
Metyrosine
Flibanserin
The risk or severity of hypertension can be increased when Dutasteride is combined with Flibanserin.
Metyrosine
Lysergic acid diethylamide
The risk or severity of hypertension can be increased when Dutasteride is combined with Lysergic acid diethylamide.
Metyrosine
Zomepirac
The risk or severity of hypertension can be increased when Dutasteride is combined with Zomepirac.
Metyrosine
Metamizole
The risk or severity of hypertension can be increased when Dutasteride is combined with Metamizole.
Metyrosine
Nimesulide
The risk or severity of hypertension can be increased when Dutasteride is combined with Nimesulide.
Metyrosine
Etoricoxib
The risk or severity of hypertension can be increased when Dutasteride is combined with Etoricoxib.
Metyrosine
Zuclopenthixol
The risk or severity of hypertension can be increased when Dutasteride is combined with Zuclopenthixol.
Metyrosine
Solifenacin
The risk or severity of hypertension can be increased when Dutasteride is combined with Solifenacin.
Metyrosine
Antipyrine
The risk or severity of hypertension can be increased when Dutasteride is combined with Antipyrine.
Metyrosine
Aminophenazone
The risk or severity of hypertension can be increased when Dutasteride is combined with Aminophenazone.
Metyrosine
Yohimbine
The risk or severity of hypertension can be increased when Dutasteride is combined with Yohimbine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3